Meloxicam Unichem (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for converting arachidonic acid into prostaglandins that cause inflammation, pain, and fever. By reducing prostaglandin synthesis, meloxicam diminishes these symptoms while preserving COX‑1 activity that protects the stomach lining.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function, and other factors. Typical adult regimens range from low to moderate daily doses, but exact dosing must be individualized and documented by the prescriber.

Safety of meloxicam during pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Meloxicam Unichem. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a relatively selective COX‑2 inhibition profile, which may provide a lower risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, cardiovascular and renal safety considerations remain similar, and choice of NSAID should be guided by individual patient risk factors.

Store Meloxicam Unichem tablets at ambient temperature, preferably below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and do not use after the expiration date printed on the packaging.

Meloxicam Unichem is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce possible stomach upset. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious adverse events include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, acute kidney injury, severe skin reactions, and liver dysfunction. Patients should seek immediate medical attention if they experience symptoms like black stools, chest pain, sudden swelling, rash, or jaundice.

Meloxicam is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, and patients with severe renal or hepatic impairment. It should also be avoided in the third trimester of pregnancy.